| 000 | 01114 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516132532.0 | ||
| 264 | 0 | _c20131025 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1875-9114 | ||
| 024 | 7 |
_a10.1002/phar.1173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeFrates, Sean R | |
| 245 | 0 | 0 |
_aThe reversal of inhibitors in congenital hemophilia. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cFeb 2013 |
||
| 300 |
_a157-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
| 650 | 0 | 4 |
_aFactor IX _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFactor VIII _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmune Tolerance _ximmunology |
| 650 | 0 | 4 |
_aIsoantibodies _xbiosynthesis |
| 650 | 0 | 4 | _aRituximab |
| 700 | 1 | _aMcDonagh, Kevin T | |
| 700 | 1 | _aAdams, Val R | |
| 773 | 0 |
_tPharmacotherapy _gvol. 33 _gno. 2 _gp. 157-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/phar.1173 _zAvailable from publisher's website |
| 999 |
_c22452702 _d22452702 |
||